Dawnrays Pharmaceutical Holdings Ltd. (2348)
Market Closed
13 Aug, 08:00
HKEX HKEX Primary 1. 02
HKD +0.01
+0.9901%
1.86B Market Cap
- P/E Ratio
0.03% Div Yield
180,000 Volume
- Eps
1.01 HKD
Previous Close Want to track 2348 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
2348 closed today higher at 1.02 HKD, an increase of 0.9901% from yesterday's close, completing a monthly increase of 2% or 0.02 HKD. Over the past 12 months, 2348 stock lost -16.3934%.
2348 pays dividends to its shareholders, with the most recent payment made on Jun 12, 2026. The next estimated payment will be in In 3 months on Dec 12, 2026 for a total of 0.048 HKD.
The last earnings report, released on Mar 20, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Dawnrays Pharmaceutical Holdings Ltd. has completed 1 stock splits, with the recent split occurring on Aug 06, 2018.
The company's stock is traded on one exchange.
2348 Chart
People also search for
Dawnrays Pharmaceutical Holdings Ltd. (2348) FAQ
What is the stock price today?
The current price is 1.02 HKD.
On which exchange is it traded?
Dawnrays Pharmaceutical Holdings Ltd. is listed on HKEX.
What is its stock symbol?
The ticker symbol is 2348.
Does it pay dividends? What is the current yield?
Yes, It pays dividends and the current yield is 0.03%.
What is its market cap?
As of today, the market cap is 1.86B.
Has Dawnrays Pharmaceutical Holdings Ltd. ever had a stock split?
Dawnrays Pharmaceutical Holdings Ltd. had 1 splits and the recent split was on Aug 06, 2018.
Dawnrays Pharmaceutical Holdings Ltd. Profile
| Specialty Retail Industry | Consumer Discretionary Sector | - CEO | HKEX Exchange | G2687M100 CUSIP |
| Hong Kong Country | 1,116 Employees | 27 May 2026 Last Dividend | 6 Aug 2018 Last Split | - IPO Date |
Overview
Dawnrays Pharmaceutical (Holdings) Limited operates as an investment holding company with a core focus on the development, manufacturing, and sale of non-patented pharmaceutical medicines. Established in 1995, the company has carved a niche for itself both in Mainland China and the international market. Dawnrays Pharmaceutical caters to diverse medical needs through its two operational segments: Intermediates and Bulk Medicines, and Finished Drugs. The company's strategic headquarters is located in Wan Chai, Hong Kong, positioning it well to serve its extensive global and domestic customer base.
Products and Services
Dawnrays Pharmaceutical offers a wide range of pharmaceutical products and services designed to meet various healthcare needs. These include:
- Antibiotics: The company specializes in the production of pharmaceutical intermediates and bulk medicines. It also produces powder for injections and oral antibiotics, catering to the need for effective treatment options against bacterial infections.
- System Specific Medicines: Dawnrays offers an assortment of drugs targeted at specific systems within the body, ensuring a comprehensive approach to healthcare. This includes:
- Cardiovascular system drugs: Medicines aimed at treating conditions related to the heart and blood vessels.
- Anti-allergic, anti-HBV, and digestive systems drugs: Treatments focused on alleviating allergies, combating hepatitis B virus (HBV), and aiding digestive health.
- Urinary system drugs: Medicines designed to address urinary system issues, ensuring proper kidney and bladder function.
- Anti-pyretic analgesic, respiratory, and endocrine system drugs: Comprehensive solutions for fever and pain relief, respiratory conditions, and hormonal imbalances, available in various forms such as tablets, capsules, and granules.
Contact Information
Address: CNT Tower
Phone: 852 2111 9708
Website: https://www.dawnrays.com
